Study finds reduced risk of cataracts associated with obesity surgery
New research presented at this year’s European Congress on Obesity (held online 10-13 May) has found a reduced risk of eye cataracts occurring in patients who...
New research presented at this year’s European Congress on Obesity (held online 10-13 May) has found a reduced risk of eye cataracts occurring in patients who...
The STEP trials published over the past year have established the efficacy and safety of semaglutide in treating patients with obesity. A new study analysing the...
New research presented at this year’s European Congress on Obesity (held online, 10-13 May) shows that treatment with the drug semaglutide reduces body weight in adults...
Researchers running the University of Oxford-led Com-COV study—launched earlier this year to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine—have today reported preliminary...
A new, noninvasive method for measuring brain blood flow with light has been developed by biomedical engineers and neurologists at the University of California, Davis, and...
New research presented at this year’s European Congress on Obesity (held online, 10-13 May) shows that the obesity drug semaglutide reduces appetite, food cravings and energy...
An early study of a new experimental drug to treat obesity known as cagrilintide shows that, when combined with semaglutide 2.4 mg, the combination leads to...
The government’s COVID-19 travel plan will let new variants into the UK, warn experts in The BMJ today.
Delaying the second dose of COVID-19 vaccines, at least for people aged under 65, could result in up to 20% lower mortality, but only under certain...
The catastrophic scale of the COVID-19 pandemic could have been prevented, an independent global panel concluded Wednesday, but a “toxic cocktail” of dithering and poor coordination...